SCHEMBL9744239

SCHEMBL9744239

[NH]c1ccc(N(CCCl)CCCl)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 5/20 0.44
ERBB2 P04626 5/20 0.44
ALDH1A1 P00352 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
HIF1A Q16665 3/20 0.44
LMNA P02545 3/20 0.44
MAPT P10636 2/20 0.44
NFKB1 P19838 2/20 0.44
THPO P40225 2/20 0.44
PMP22 Q01453 2/20 0.44
GMNN O75496 1/20 0.44
CYP2D6 P10635 1/20 0.44
GABRA1 P14867 1/20 0.44
TSHR P16473 1/20 0.44
GABRA2 P47869 1/20 0.44
GABRB2 P47870 1/20 0.44
SLCO1B3 Q9NPD5 1/20 0.44
CYP3A4 P08684 3/20 0.43
ALOX15 P16050 2/20 0.43
KMT2A Q03164 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8599765 0.78 KMT2A (0.48) EGFRERBB2ALDH1A1SMN1; SMN2HIF1A
SCHEMBL28878101 0.76 ALDH1A1 (0.52) EGFRERBB2ALDH1A1SMN1; SMN2HIF1A
SCHEMBL14714244 0.76 HDAC6 (0.45) EGFRERBB2ALDH1A1SMN1; SMN2HIF1A
SCHEMBL1269424 0.76 CYP3A4 (0.54) EGFRERBB2ALDH1A1SMN1; SMN2HIF1A
SCHEMBL10600036 0.76 EGFR (0.41) EGFRERBB2ALDH1A1SMN1; SMN2MAPT
SCHEMBL6744975 0.76 EGFR (0.44) EGFRERBB2ALDH1A1SMN1; SMN2HIF1A
SCHEMBL5987618 0.76 EGFR (0.44) EGFRERBB2ALDH1A1SMN1; SMN2HIF1A
SCHEMBL905253 0.76 EGFR (0.49) EGFRERBB2ALDH1A1SMN1; SMN2HIF1A
SCHEMBL9889321 0.76 CNR2 (0.53) EGFRERBB2ALDH1A1SMN1; SMN2HIF1A
SCHEMBL121635 0.75 EGFR (0.58) EGFRERBB2ALDH1A1SMN1; SMN2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0484870-A2 Prodrugs for beta-lactamase and uses thereof Bristol-Myers Squibb Company (US) 1992-05-13 EP claimed